4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-025578
CEO and Director bought 10,308 shares at $2.80 ($28,862)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2022-09-08 | Purchase | +10,308 | $2.80 | $28,862 | 65,374 | D |
| Open-market purchases · 10,308 sh · avg $2.80 · $28,862 | |||||||
Loading xslF345X03/ownership.xml…